Evonik and Genedata Broaden their Collaboration with the Genedata Selector Biotechnology Data Management Platform
Genomic strain data management solution supports Evonik growth in biotechnology
September 17, 2013
Genedata, a leading provider of advanced software solutions for industrial, agricultural, drug discovery, and life science research, today announced that Evonik is extending its collaboration with Genedata. Building on its long-standing partnership with Genedata, Evonik is using the Genedata fully integrated offering that includes Genedata Selector™ for the management and analysis of strain information, scientific data analysis consulting provided by Genedata bioinformatics experts, and specialized IT services. The integrated solution from Genedata will help Evonik advance its industry diversification projects and strengthen the return on its strategic biotechnology investments.
“New, data-intensive and omics-based technologies are catalysts for innovation in the health and food industries,” noted Dr. Ralf Kelle, vice president of R&D Bioproducts for the Evonik Health and Nutrition business unit. “Genedata—with its domain expertise in data analysis and management—helps us get maximum value from our data. More importantly, our relationship with Genedata allows us to benefit from their innovative solutions, which contribute to the success of our resource-efficient and sustainable biotechnology research.”
Beyond Software—Scientific Data Analysis Consulting & Specialized IT Services
Evonik has successfully used Genedata Selector to manage, visualize, and analyze complete genomes of production strain collections with a focus on mutation analysis and deciphering complex genotype-phenotype relationships. Genedata Selector accelerates difficult strain optimization projects for the production of bio-based chemicals, nutritional proteins, food and feed additives, and cosmetics ingredients.
Now, in addition to Genedata Selector enterprise software, Evonik will also use Genedata scientific data analysis consulting services. Based on in-depth and extensive experience in the industrial biotechnology field, these value-added services help to eliminate resource bottlenecks, provide cost-effective support for strategically important projects, and deliver valuable results quickly and efficiently.
Addressing the complete life cycle of R&D projects – from early-stage feasibility studies to late-stage product development—Genedata scientific data analysis consulting delivers:
- proprietary genome annotations, including gene calling and functional annotations up to the pathway level (for prokaryotes as well as eukaryotes);
- production strain comparisons, including interpretations of biological effects of variants (e.g. on enzyme activities);
- cellular signaling network reconstructions for proprietary strains, based on expression and regulatory sequence data;
- biomarkers, based on omics, NGS, pathway, and functional annotation data; and
- statistical expression analysis reports (e.g. of microarray or RNAseq data).
In the enterprise R&D environment, Genedata specialized IT services ensure server availability and infrastructure stability for high-performance server infrastructures. These services, which empower researchers to focus more on scientific discovery, include:
- hosting and remote server maintenance;
- software and database integration services; and
- data migration and integration services, including public domain genome release monitoring.
“We are proud of our long-standing and successful partnership with Evonik, a world leader in specialty chemicals,” noted Dr. Othmar Pfannes, CEO of Genedata. “Their adoption of the Genedata Selector application suite, coupled with our scientific consulting and professional IT services, serves as an industry model for other customers in industrial biotechnology research who want to leverage the full advantage of our bioinformatics expertise to achieve their business objectives.”
Genedata transforms data into intelligence with innovative software solutions that incorporate extensive biopharma R&D domain knowledge. Multinational biopharmaceutical organizations and cutting-edge biotechs around the globe rely on Genedata to digitalize and automate data-rich and complex R&D processes. From early discovery all the way to the clinic, Genedata solutions help maximize the ROI in R&D expenditure. Founded in 1997, Genedata is headquartered in Basel, Switzerland with additional offices in Boston, London, Munich, San Francisco, Singapore, and Tokyo.
LinkedIn | Twitter | YouTube
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
All product and service names mentioned are the trademarks of their respective companies.